| Entry |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Flavoxate hydrochloride (JP18/USP); Urispas (TN) | ||||||||||
| Product | |||||||||||
| Generic | FLAVOXATE HYDROCHLORIDE (AvPAK), FLAVOXATE HYDROCHLORIDE (Epic Pharma), FLAVOXATE HYDROCHLORIDE (Padagis US LLC), FLAVOXATE HYDROCHLORIDE (PuraCap Laboratories LLC dba Blu Pharmaceuticals) | ||||||||||
| Formula | C24H25NO4. HCl | ||||||||||
| Exact mass | 427.155 | ||||||||||
| Mol weight | 427.9205 | ||||||||||
| Structure |  | ||||||||||
| Simcomp | |||||||||||
| Remark |
| ||||||||||
| Efficacy | Antipollakisuria, Phosphodiesterase inhibitor | ||||||||||
| Target | PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437] | ||||||||||
| Pathway |
| ||||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] G GENITO URINARY SYSTEM AND SEX HORMONES G04 UROLOGICALS G04B UROLOGICALS G04BD Urinary antispasmodics G04BD02 Flavoxate D00718 Flavoxate hydrochloride (JP18/USP) <JP/US> USP drug classification [BR:br08302] Genitourinary Agents Antispasmodics, Urinary Flavoxate D00718 Flavoxate hydrochloride (JP18/USP) Therapeutic category of drugs in Japan [BR:br08301] 2 Agents affecting individual organs 25 Urogenital and anal organ agents 259 Miscellaneous 2590 Miscellaneous D00718 Flavoxate hydrochloride (JP18/USP) Classification of Japanese OTC drugs [BR:br08313] Agents for urogenital organs and anus 31 Other drugs for urogenital organs and anus D00718 Flavoxate hydrochloride (JP18/USP) Drugs for women 51 Other drugs for women D00718 Flavoxate hydrochloride (JP18/USP) Risk category of Japanese OTC drugs [BR:br08312] Designated second-class OTC drugs Inorganic and organic chemicals Flavoxate D00718 Flavoxate hydrochloride (JP18/USP) Second-class OTC drugs Inorganic and organic chemicals Flavoxate D00718 Flavoxate hydrochloride (JP18/USP) Target-based classification of drugs [BR:br08310] Enzymes Hydrolases (EC3) Phosphodiesterases PDE D00718 Flavoxate hydrochloride (JP18/USP) <JP/US> Drugs listed in the Japanese Pharmacopoeia [BR:br08311] Chemicals D00718 Flavoxate hydrochloride Rx-to-OTC switch list in Japan [br08314.html] D00718 | ||||||||||
| Other DBs |
| ||||||||||
| KCF data | ATOM 30 1 C8y C 24.0202 -17.4177 2 C8y C 24.0144 -18.8212 3 C8y C 22.8088 -16.7128 4 O2x O 25.2375 -16.7187 5 C8y C 25.2258 -19.5202 6 C8x C 22.8088 -19.5143 7 C7a C 22.8146 -15.3150 8 C8x C 21.5915 -17.4177 9 C8y C 26.4490 -17.4293 10 C8y C 26.4431 -18.8270 11 O5x O 25.2201 -20.9180 12 C8x C 21.5915 -18.8212 13 O7a O 21.5973 -14.6161 14 O6a O 24.0261 -14.6161 15 C8y C 27.6604 -16.7304 16 C1a C 27.6487 -19.5318 17 C1b C 20.3859 -15.3092 18 C8x C 28.8660 -17.4410 19 C8x C 27.6604 -15.3325 20 C1b C 19.1745 -14.6103 21 C8x C 30.0833 -16.7420 22 C8x C 28.8777 -14.6394 23 N1y N 17.9630 -15.3092 24 C8x C 30.0890 -15.3442 25 C1x C 16.7516 -14.6103 26 C1x C 17.9630 -16.7071 27 C1x C 15.5401 -15.3033 28 C1x C 16.7516 -17.4117 29 C1x C 15.5343 -16.7012 30 X Cl 18.1611 -19.7647 BOND 32 1 1 2 1 2 1 3 2 3 1 4 1 4 2 5 1 5 2 6 2 6 3 7 1 7 3 8 1 8 4 9 1 9 5 10 1 10 5 11 2 11 6 12 1 12 7 13 1 13 7 14 2 14 9 15 1 15 10 16 1 16 13 17 1 17 15 18 2 18 15 19 1 19 17 20 1 20 18 21 1 21 19 22 2 22 20 23 1 23 21 24 2 24 23 25 1 25 23 26 1 26 25 27 1 27 26 28 1 28 27 29 1 29 8 12 2 30 9 10 2 31 22 24 1 32 28 29 1 |